# Red Team Report: PR Description -- INSTALLATION.md Rewrite

**Strategy:** S-001 Red Team Analysis
**Deliverable:** `/tmp/pr-description.md` (PR description for INSTALLATION.md rewrite)
**Criticality:** C4 (applied as requested; PR description summarizes C4-reviewed work)
**Date:** 2026-02-25
**Reviewer:** adv-executor (S-001)
**H-16 Compliance:** H-16 applies to S-002 (Devil's Advocate), not S-001 directly. This execution is a standalone Red Team requested outside the standard tournament ordering. No S-003 Steelman output provided for this PR description specifically. Proceeding with analysis noting this gap.
**Threat Actor:** Skeptical senior PR reviewer with full codebase access, Claude Code plugin system expertise, and motivation to find grounds to block or request changes before merge.

---

## Summary

The PR description makes several verifiable technical claims, presents a quality score progression table, and lists a test plan -- all of which a skeptical reviewer would probe for completeness, accuracy, and traceability. The threat actor finds five exploitable surfaces: unverified numeric claims (agent count "54 to 58"), a quality table whose "REVISE" verdict labeling contradicts the score progression narrative, test plan gaps that omit regression testing for the document type PATH_PATTERNS change, missing scope disclosure about what was removed from INSTALLATION.md, and a research provenance claim that cannot be independently verified without reading a linked file. Two findings are Major; three are Minor. Recommendation: ACCEPT with targeted revisions to the two Major findings before merge.

---

## Findings Table

| ID | Attack Vector | Category | Exploitability | Severity | Priority | Defense | Affected Dimension |
|----|---------------|----------|----------------|----------|----------|---------|-------------------|
| RT-001-20260225 | Agent count "54 to 58" is unverifiable from PR description alone -- no diff shown | Dependency | High | Major | P1 | Missing | Evidence Quality |
| RT-002-20260225 | Quality table shows "REVISE" for iteration 3 (0.93) and iteration 4 (0.94) but text says these "converged" to PASS -- the verdict column contradicts the narrative framing | Ambiguity | High | Major | P1 | Missing | Internal Consistency |
| RT-003-20260225 | Test plan omits regression test for PATH_PATTERNS change -- a code change with no test listed | Boundary | Medium | Minor | P2 | Partial | Completeness |
| RT-004-20260225 | "Removes misleading marketplace-first language" does not specify what was removed -- a reviewer cannot assess removal scope without reading the diff | Ambiguity | Medium | Minor | P2 | Missing | Completeness |
| RT-005-20260225 | Research provenance claim ("verified via Context7 docs and web search") cannot be assessed without clicking the linked research file -- claim is self-referential | Degradation | Low | Minor | P2 | Partial | Evidence Quality |

---

## Detailed Findings

### RT-001-20260225: Unverifiable Agent Count Claim [MAJOR]

**Attack Vector:** The PR description claims `marketplace.json` agent count was corrected from "stale '54' to verified '58'." A skeptical reviewer will immediately ask: verified how? The PR description provides no diff excerpt, no command output (`ls skills/*/agents/*.md | wc -l`), and no reference to the file state before and after. The reviewer cannot confirm "58" is accurate without independently running the count or reading the diff.

**Category:** Dependency (relies on external verification by reviewer)

**Exploitability:** High -- The description states the count is "verified" but provides no verification evidence. The word "verified" is doing work it hasn't earned in this context.

**Severity:** Major -- If the count is wrong (e.g., the PR itself adds or removes agent files), the description contains a false claim that shipped to the main branch. A reviewer who approves without checking is now responsible for an inaccurate `marketplace.json`.

**Existing Defense:** The test plan includes "Confirm `marketplace.json` agent count matches `ls skills/*/agents/*.md | wc -l`" -- but this is a manual test checkbox, not inline evidence. The test is listed as unchecked (empty `[ ]`), meaning the verification has not yet occurred at PR description time.

**Evidence:** From the PR description:
> "Corrects marketplace.json agent count from stale '54' to verified '58'"

And from the test plan:
> "- [ ] Confirm `marketplace.json` agent count matches `ls skills/*/agents/*.md | wc -l`"

The unchecked test checkbox reveals the claim is prospective, not verified.

**Dimension:** Evidence Quality

**Countermeasure:** Either (a) pre-fill the test plan item with actual command output showing the count, or (b) change the claim language from "verified '58'" to "updated to '58' (to be verified per test plan)" to avoid asserting verification that hasn't happened yet.

**Acceptance Criteria:** The PR description either shows command output confirming the count OR uses language that accurately represents the verification status as prospective.

---

### RT-002-20260225: Quality Table Verdict Column Contradicts Narrative [MAJOR]

**Attack Vector:** The quality table shows iterations 3 and 4 scoring 0.93 and 0.94 respectively, both labeled "REVISE." However, 0.93 and 0.94 exceed the stated PASS threshold of >= 0.92. The Summary section says the PR "went through 5 iterations of C4 adversarial review" with "converging scores" -- but the table's own verdicts say iterations 3 and 4 were REVISE, not PASS. A skeptical reviewer will either (a) conclude the quality gate threshold is not >= 0.92 for this work, (b) question whether the REVISE labeling is intentional for some unstated reason, or (c) lose trust in the quality process description entirely.

**Category:** Ambiguity (the verdict column's semantics are undefined in context)

**Exploitability:** High -- The contradiction is visible in the table itself without any external knowledge. Any reviewer reading the PR description carefully will catch this immediately.

**Severity:** Major -- A quality table that is internally inconsistent undermines the entire "C4 adversarial review" credibility claim. If the reviewer cannot trust the table, they cannot assess whether the quality process was followed correctly.

**Existing Defense:** None -- the table is self-contradicting with no explanatory footnote.

**Evidence:** From the PR description:
> | 3 | 0.93 | REVISE | S-001, S-002, S-007, S-014, Voice |
> | 4 | 0.94 | REVISE | S-014, Voice |

The quality gate is documented in `quality-enforcement.md` as >= 0.92 = PASS. By that standard, iterations 3 and 4 should be labeled PASS, not REVISE.

**Dimension:** Internal Consistency

**Countermeasure:** One of three options: (a) correct the Verdict column for iterations 3 and 4 to "PASS" if the quality gate was met, (b) add a footnote explaining that the author chose to continue running strategies even after reaching the threshold (optional additional iterations), or (c) relabel the column as "Action Taken" rather than "Verdict" to clarify that "REVISE" means another iteration was run, not that the score failed. Option (b) or (c) would be most honest if the author deliberately ran extra iterations.

**Acceptance Criteria:** The quality table's Verdict column is internally consistent with the stated quality gate threshold (>= 0.92 = PASS), or the labeling is explained with a clarifying footnote.

---

### RT-003-20260225: Test Plan Gap -- PATH_PATTERNS Change Untested [MINOR]

**Attack Vector:** The PR description bullet point states: "Updates document type PATH_PATTERNS to recognize `projects/*/reviews/` files." This is a code change (to document type ontology), not a documentation change. The test plan's last item reads: "Verify pre-commit tests pass (document type regression, category validation)" -- but this is a single undifferentiated checkbox for all pre-commit tests, not a specific test for the PATH_PATTERNS addition. A reviewer who cares about regression risk will note that adding a path pattern without a specific test case is an exploitable gap.

**Category:** Boundary (boundary between documentation changes and code changes is not respected in test plan specificity)

**Exploitability:** Medium -- The pre-commit hook does exercise document type validation, but the test plan doesn't call out what would happen if `projects/*/reviews/` is NOT recognized (e.g., existing review files in the moved location would fail validation).

**Severity:** Minor -- The pre-commit test suite likely catches obvious failures, but the test plan doesn't demonstrate awareness of the specific regression scenario introduced by the path pattern change.

**Existing Defense:** Partial -- "Verify pre-commit tests pass (document type regression, category validation)" covers this obliquely.

**Evidence:** From the PR description:
> "Updates document type PATH_PATTERNS to recognize `projects/*/reviews/` files"
> "- [ ] Verify pre-commit tests pass (document type regression, category validation)"

**Countermeasure:** Add a specific test plan item: "Verify `projects/PROJ-001-oss-documentation/reviews/` files are recognized by document type validation (not flagged as unknown type)."

**Acceptance Criteria:** Test plan explicitly confirms the new PATH_PATTERN addition is covered by a specific validation step.

---

### RT-004-20260225: Removal Scope Undisclosed [MINOR]

**Attack Vector:** The first bullet states the PR "removes misleading marketplace-first language" from INSTALLATION.md. A reviewer cannot assess whether the removal is complete, appropriate, or potentially over-broad without knowing what was removed. The PR description describes additions (four install methods, orientation content, Windows fix, air-gapped path) but not what was deleted. For a rewrite of a user-facing installation guide, deletions are as important as additions -- a removed step that some users relied on represents a regression.

**Category:** Ambiguity (scope of removal is undefined)

**Exploitability:** Medium -- The reviewer must diff the file to assess deletion scope, which is reasonable for a code review but the PR description should surface any meaningful content removal.

**Severity:** Minor -- The rewrite context implies substantial deletion is expected and intentional. However, if any prior installation method or troubleshooting content was removed, users following bookmarked links to that content would hit 404 or missing sections.

**Existing Defense:** Missing -- No mention of what was removed or what migration path exists for users who followed the old instructions.

**Evidence:** From the PR description:
> "Rewrites INSTALLATION.md with four clear install methods (SSH, HTTPS, Local Clone, Session Install) and removes misleading marketplace-first language"

The previous structure of INSTALLATION.md is not described.

**Countermeasure:** Add one sentence to the Summary describing the prior structure that was removed (e.g., "The previous guide opened with marketplace installation steps that referenced a non-existent Anthropic marketplace listing; these have been fully replaced").

**Acceptance Criteria:** PR description gives reviewers sufficient context to understand what content was removed, without requiring them to read the full diff before forming an opinion.

---

### RT-005-20260225: Research Claim Self-Referential Without Inline Evidence [MINOR]

**Attack Vector:** The Research section states: "Plugin system behavior verified via Context7 docs and web search." The four bullet points that follow are key findings, but the verification source is a linked file (`projects/PROJ-001-oss-documentation/research/claude-code-plugin-system-research-20260225.md`). A reviewer cannot assess the quality of the research without following the link. The claim "verified via Context7 docs" is not itself verifiable from the PR description -- it is a trust assertion.

**Category:** Degradation (research provenance degrades to a trust claim without inline evidence)

**Exploitability:** Low -- Most reviewers will accept research summaries in PR descriptions at face value. The risk is low but real: if a key research finding is wrong (e.g., "Community marketplaces have auto-update disabled by default" -- is this still true in the current Claude Code version?), the PR description provides no way to spot-check it.

**Severity:** Minor -- The research file is linked and available; this is a quality concern, not a blocking issue.

**Existing Defense:** Partial -- The research file path is provided, allowing reviewers to verify if they choose.

**Evidence:** From the PR description:
> "Plugin system behavior verified via Context7 docs and web search. Research persisted to `projects/PROJ-001-oss-documentation/research/claude-code-plugin-system-research-20260225.md`."

**Countermeasure:** Either (a) add the Context7 library ID or a specific documentation URL for the most critical research finding ("Community plugins require manual `marketplace add` before `install`"), or (b) note the Claude Code version against which the research was conducted, since plugin system behavior may change between releases.

**Acceptance Criteria:** At least one research finding is anchored to a specific, checkable source (URL, library version, or Claude Code release version).

---

## Recommendations

### P0 (Critical -- MUST mitigate before merge)

None identified.

### P1 (Important -- SHOULD mitigate)

**RT-001:** Change "verified '58'" to "updated to '58'" OR add inline command output showing the count. The test plan item should remain as a final check, but the description should not claim verification before the test is run.

**RT-002:** Fix the quality table Verdict column. Options:
- Label iterations 3 and 4 as "PASS" if they met the >= 0.92 threshold
- Add a footnote: "Iterations 3-4 met the PASS threshold but review continued to address voice and completeness concerns"
- Rename the column "Action" to clarify "REVISE" means another iteration was run, not that the score failed

### P2 (Monitor -- MAY mitigate)

**RT-003:** Add specific test plan item for PATH_PATTERNS validation covering `projects/*/reviews/` files.

**RT-004:** Add one sentence describing what content was removed from the prior INSTALLATION.md.

**RT-005:** Anchor the most critical research finding to a specific Claude Code version or documentation URL.

---

## Scoring Impact

| Dimension | Weight | Impact | Rationale |
|-----------|--------|--------|-----------|
| Completeness | 0.20 | Negative | RT-003: Test plan gap for PATH_PATTERNS change; RT-004: Deletion scope undisclosed. Neither is critical, but completeness of the PR description is reduced. |
| Internal Consistency | 0.20 | Negative | RT-002: Quality table Verdict column directly contradicts the >= 0.92 PASS threshold. This is the most damaging finding -- it calls into question the quality process narrative. |
| Methodological Rigor | 0.20 | Neutral | The PR description accurately describes the multi-iteration C4 review approach. The methodology is sound; the presentation has a labeling error. |
| Evidence Quality | 0.15 | Negative | RT-001: Unverified agent count claim uses "verified" language for an unchecked test plan item. RT-005: Research provenance is a trust assertion, not anchored evidence. |
| Actionability | 0.15 | Positive | The test plan is actionable and specific. The install method descriptions are clear. The file movement changes are traceable. |
| Traceability | 0.10 | Neutral | Research file path is provided. Review artifacts directory is referenced. But the quality table inconsistency (RT-002) reduces traceability of the quality process. |

---

## Execution Statistics

- **Total Findings:** 5
- **Critical:** 0
- **Major:** 2 (RT-001, RT-002)
- **Minor:** 3 (RT-003, RT-004, RT-005)
- **Protocol Steps Completed:** 5 of 5
- **Attack Categories Covered:** Ambiguity (RT-002, RT-004), Boundary (RT-003), Dependency (RT-001), Degradation (RT-005) -- 4 of 5 categories (Rule Circumvention not applicable to a PR description artifact)

---

## Execution Context

- **Strategy:** S-001 Red Team Analysis
- **Template:** `.context/templates/adversarial/s-001-red-team.md`
- **Deliverable:** PR description (docs/installation-rewrite branch)
- **Executed:** 2026-02-25
- **Finding Prefix:** RT-NNN-20260225
